Solventum Corporation (BMV:SOLV)

Market Cap	232.69B -11.2%
Revenue (ttm)	154.11B +2.3%
Net Income	27.95B +111.7%
EPS	159.93 +110.2%
Shares Out	n/a
PE Ratio	8.32
Forward PE	12.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16
Average Volume	73
Open	1,338.00
Previous Close	1,310.00
Day's Range	1,338.00 - 1,338.00
52-Week Range	1,273.00 - 1,700.00
Beta	n/a
RSI	46.51
Earnings Date	Feb 26, 2026

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical e...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: SOLV

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD